0001022079-21-000113.txt : 20210728
0001022079-21-000113.hdr.sgml : 20210728
20210728161833
ACCESSION NUMBER: 0001022079-21-000113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210727
FILED AS OF DATE: 20210728
DATE AS OF CHANGE: 20210728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WILENSKY GAIL R
CENTRAL INDEX KEY: 0001018538
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 211122760
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_162750349054685.xml
FORM 4
X0306
4
2021-07-27
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001018538
WILENSKY GAIL R
500 PLAZA DRIVE
SECAUCUS
NJ
07094
1
0
0
0
Common Stock
2021-07-27
4
M
0
6111
57.565
A
23956
D
Common Stock
2021-07-27
4
S
0
6111
139.323
D
17845
D
Common Stock
2021-07-27
4
M
0
6111
61.225
A
23956
D
Common Stock
2021-07-27
4
S
0
6111
139.268
D
17845
D
Common Stock
13375
I
by Trust
Stock Options (Right to Buy)
57.565
2021-07-27
4
M
0
6111
57.565
D
2022-05-11
Common Stock
6111.0
0
D
Stock Options (Right to Buy)
61.225
2021-07-27
4
M
0
6111
61.225
D
2023-05-21
Common Stock
6111.0
0
D
This transaction was executed in multiple trades at prices ranging from $139.28 to $139.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $139.26 to $139.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.
The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.
William J. O'Shaughnessy, Jr., Attorney in Fact for Gail R. Wilensky
2021-07-28